GE HealthCare Technologies Inc. with ticker code (GEHC) have now 12 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between $97.00 and $66.00 calculating the mean target price we have $83.88. Given that the stocks previous close was at $76.62 this would indicate that there is a potential upside of 9.5%. There is a 50 day moving average of $71.94 and the 200 moving average now moves to $74.38. The market capitalization for the company is 35.22B. The current share price for the company is: $77.36 USD
The potential market cap would be $38,554,585,369 based on the market consensus.
The company has a dividend yield of 0.77%. Other points of data to note are a P/E ratio of 22.96, revenue per share of $42.36 and a 6.17% return on assets.
GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics, and digital solutions company. The Company develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. The Company’s segments include Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The Imaging segment includes scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment includes medical devices, services, consumable products, services, and digital solutions. The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the global radiology and nuclear medicine industry.
